Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (41-50 of 451) with videos related to

Pageof 46
Sort By:
BMJ (Clinical Research Ed.)|August 6, 2009
Treatment of chronic gastro-oesophageal reflux diseaseAlexander C Ford, Paul Moayyedi
Gastroenterology|March 27, 2014
Diagnosing irritable bowel syndrome with a combination of biomarkers and "psychomarkers"Ruchit Sood, Alexander C Ford
Therapeutic Advances in Chronic Disease|November 2, 2013
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndromeRuchit Sood, Alexander C Ford
Clinical and Translational Gastroenterology|October 9, 2015
Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the PastRuchit Sood, Alexander C Ford
Journal of Clinical Medicine|October 28, 2017
Pharmacotherapy for Irritable Bowel SyndromeMichael Camilleri, Alexander C Ford
Gut|April 16, 2015
Efficacy of mesalazine in IBSThazin Min, Alexander C Ford
Gastroenterology|March 1, 2016
Poor Correlation Between Patient-reported and Endoscopic Components of the Mayo Score in Ulcerative ColitisAnthony O'Connor, Alexander C Ford
Gastroenterology|March 7, 2018
Histologic Criteria to Define Irritable Bowel Syndrome: Within the Realms of Possibility?Ruchit Sood, Alexander C Ford
Therapeutic Advances in Gastroenterology|June 23, 2011
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agentsAnita Sainsbury, Alexander C Ford
Annals of Internal Medicine|October 7, 2009
Redundant data in the meta-analysis on Helicobacter pylori eradicationAlexander C Ford, Paul Moayyedi
Pageof 46

Showing results (41-50 of 451) with videos related to

Sort By:
Pageof 46
BMJ (Clinical Research Ed.)|August 6, 2009
Treatment of chronic gastro-oesophageal reflux diseaseAlexander C Ford, Paul Moayyedi
Gastroenterology|March 27, 2014
Diagnosing irritable bowel syndrome with a combination of biomarkers and "psychomarkers"Ruchit Sood, Alexander C Ford
Therapeutic Advances in Chronic Disease|November 2, 2013
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndromeRuchit Sood, Alexander C Ford
Clinical and Translational Gastroenterology|October 9, 2015
Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the PastRuchit Sood, Alexander C Ford
Journal of Clinical Medicine|October 28, 2017
Pharmacotherapy for Irritable Bowel SyndromeMichael Camilleri, Alexander C Ford
Gut|April 16, 2015
Efficacy of mesalazine in IBSThazin Min, Alexander C Ford
Gastroenterology|March 1, 2016
Poor Correlation Between Patient-reported and Endoscopic Components of the Mayo Score in Ulcerative ColitisAnthony O'Connor, Alexander C Ford
Gastroenterology|March 7, 2018
Histologic Criteria to Define Irritable Bowel Syndrome: Within the Realms of Possibility?Ruchit Sood, Alexander C Ford
Therapeutic Advances in Gastroenterology|June 23, 2011
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agentsAnita Sainsbury, Alexander C Ford
Annals of Internal Medicine|October 7, 2009
Redundant data in the meta-analysis on Helicobacter pylori eradicationAlexander C Ford, Paul Moayyedi
Pageof 46